The company also reported record Q4 2023 revenue of $698,591, up 403% over the previous quarter. Elevai Labs Inc. (NASDAQ:…
Read More »Elevai Stock
ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3 financial results.…
Read More »ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with…
Read More »ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced today the signing of a licensing agreement…
Read More »Shares of Elevai Labs have been approved for listing on the NASDAQ and Will Commence Trading on November 21, 2023,…
Read More »Last Updated: Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the…
Read More »Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest…
Read More »Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest…
Read More »Welcome to Wealthy VC’s Capitalist Countdown The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest…
Read More »The Capitalist Countdown is a weekly series that features the biggest stories from the market’s hottest stocks as well as news from…
Read More »